Adjustment of COVID-19 mortality data points & impact on the calibration of mortality models

Life and health insurers have had to think about how to incorporate COVID-19 into medical underwriting, and benefit and product design.

Since the beginning of the COVID-19 pandemic in early 2020, we now have much more insight into COVID-19 deaths in the US, including hopes for how the pandemic may wind down because of widespread vaccinations and protection…

In this paper, we discuss how insurers can explore their future exposures to the novel coronavirus through their ORSA.

The ramifications of COVID-19 on the mortgage credit risk market are still being assessed, but mortgage defaults are not expected to be as severe as during the global financial crisis, Milliman’s Mike Schmitz and Chris…

Milliman received responses from 30 carriers for the follow-up Milli-Byte Survey of Life Insurance Product Management and the COVID-19 pandemic.

This paper discusses actuarial perspectives for the calculation of the capital requirement related to catastrophic pandemic mortality as required by the Solvency II regulation.

The COVID-19 pandemic is raising some profound questions for risk practitioners.

As a result of the coronavirus pandemic, auto insurers may likely see short- and possibly long-term effects in their claims experience.